Wang Zi-Xuan, Liu Si-Liang, Sun Chun-Hui, Wang Qian
Department of Interventional Radiology, Qingdao Municipal Hospital, Qingdao 266000, Shandong Province, China.
World J Gastroenterol. 2008 Feb 14;14(6):931-5. doi: 10.3748/wjg.14.931.
To assess whether psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy.
Two hundred and sixty-two patients, who required hepatic arterial chemoembolization for hepatic malignancy and postembolization pain, were randomized into control group (n = 46, receiving medication) and intervention group (n = 216, receiving psychological intervention and medication in turn). The symptom checklist-90 (SCL-90) was used to scale the psychological symptoms of the patients before operation. Pain was scored with a 0 to 10 numeric rating scale (NRS-10) before and after analgesia as well as after psychological intervention (only in intervention group).
All psychological symptomatic scores measured with SCL-90 in the intervention group were higher than the normal range in Chinese (P < 0.05). The somatization, phobia and anxiety symptomatic scores were associated with pain numerical rating score before analgesia (r = 0.141, 0.157 and 0.192, respectively, P < 0.05). Patients in both groups experienced pain relief after medication, psychotherapy or psychotherapy combined with medication during the procedure (P < 0.01). Only some patients in the intervention group reported partial or entire pain relief (29.17% and 2.31%) after psychological intervention. The pain score after analgesia in the intervention group was significantly lower than that in the control group (P < 0.01).
Severe psychological distress occurs in patients with hepatic malignancy. Psychological intervention reduces pain scores significantly during hepatic arterial chemoembolization therapy and is thus, highly recommended as a complementary approach to drug analgesia.
评估心理干预是否能减轻肝动脉化疗栓塞治疗期间的栓塞后疼痛。
262例因肝恶性肿瘤需行肝动脉化疗栓塞且有栓塞后疼痛的患者被随机分为对照组(n = 46,接受药物治疗)和干预组(n = 216,依次接受心理干预和药物治疗)。采用症状自评量表90(SCL - 90)对患者术前的心理症状进行评分。在镇痛前、镇痛后以及心理干预后(仅干预组),采用0至10数字评分量表(NRS - 10)对疼痛进行评分。
干预组中用SCL - 90测得的所有心理症状评分均高于中国常模范围(P < 0.05)。躯体化、恐惧和焦虑症状评分与镇痛前的疼痛数字评分相关(分别为r = 0.141、0.157和0.192,P < 0.05)。两组患者在治疗过程中接受药物治疗、心理治疗或心理治疗联合药物治疗后疼痛均有所缓解(P < 0.01)。干预组仅部分患者在心理干预后报告疼痛部分或完全缓解(分别为29.17%和2.31%)。干预组镇痛后的疼痛评分显著低于对照组(P < 0.01)。
肝恶性肿瘤患者存在严重的心理困扰。心理干预可在肝动脉化疗栓塞治疗期间显著降低疼痛评分,因此强烈推荐作为药物镇痛的辅助方法。